Although large language models (LLMs) have the potential to transform biomedical research, their ability to reason accurately across complex, data-rich domains remains unproven. To address this ...

AI in pharma has the potential to overhaul drug discovery, clinical trials, manufacturing, and marketing by analysing vast datasets to speed up processes, reduce costs, and enable personalised ...